Barrett & Company’s Idexx Laboratories IDXX Stock Holding History

Barrett & Company’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$50.6K	Hold	90	–	–	0.02%	287
2025 Q4	$60.9K	Hold	90	–	–	0.02%	271
2025 Q3	$57.5K	Hold	90	–	–	0.02%	277
2025 Q2	$48.3K	Hold	90	–	–	0.02%	298
2025 Q1	$37.8K	Hold	90	–	–	0.02%	303
2024 Q4	$37.2K	Hold	90	–	–	0.02%	309
2024 Q3	$45.5K	Sell	90 -70	-44%	-$34K	0.02%	278
2024 Q2	$78K	Hold	160	–	–	0.04%	218
2024 Q1	$86.4K	Hold	160	–	–	0.04%	213
2023 Q4	$88.8K	Hold	160	–	–	0.05%	204
2023 Q3	$70K	Hold	160	–	–	0.04%	216
2023 Q2	$80.4K	Buy	160 +40	+33%	+$19.2K	0.05%	210
2023 Q1	$60K	Hold	120	–	–	0.04%	228
2022 Q4	$49K	Hold	120	–	–	0.03%	234
2022 Q3	$49K	Buy	+120	New	+$44.1K	0.03%	234

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barrett & Company's IDXX Position: Q1 2026 in Review

Barrett & Company held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 90 shares worth $50.6K. The position accounts for 0.02% of the portfolio, ranked #287.

Barrett & Company first reported a position in IDXX in Q3 2022 and has held it in 15 quarters since. The position peaked at $88.8K in Q4 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Barrett & Company held 90 shares of Idexx Laboratories worth $50.6K as of Q1 2026.
Barrett & Company left its Idexx Laboratories share count unchanged in Q1 2026.
Idexx Laboratories made up 0.02% of Barrett & Company's portfolio in Q1 2026, its #287 holding.
Barrett & Company first reported a position in Idexx Laboratories in Q3 2022 and has held it in 15 quarters since.
Barrett & Company's Idexx Laboratories position peaked at $88.8K in Q4 2023.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.